OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer reported a gift or transfer of 12K UTHR shares | OQRO

Home
Insider trades
United Therapeutics
Officer reported a gift or transfer of 12K UTHR shares

Insider trades

Insider trade

Officer reported a gift or transfer of 12K UTHR shares

Traded May 13, 2026 · Filed May 15, 2026

UTHUnited TherapeuticsUTHR

12K
Derivative units

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 13, 2026
Reporting period: Not applicable
Filed with the SEC: May 15, 2026

OfficerGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001673232-26-000014
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

May 15, 2026, 1:54 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Michael Benkowitz

Relationship

Officer

Officer title

PRESIDENT AND COO

Security

Stock Option

Table

Derivative (Table II)

Transaction date

May 13, 2026

Transaction code

Shares / units

11,728

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

Ownership form

Direct

Amendment

Footnotes from the filing

On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.

Around the same time

James EdgemondCFO AND TREASURER

Filed 4mo ago

10KShares · @ $117.76

Traded Jun 11 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

James Edgemond (CFO AND TREASURER) sold ~$25K of United Therapeutics

Scheduled in advanceFiled 4mo ago

James Edgemond (CFO AND TREASURER) sold ~$84K of United Therapeutics

Scheduled in advanceFiled 4mo ago